Shopping Cart
- Remove All
- Your shopping cart is currently empty
Prisotinol, an aminoalkyl-5-pyridinol compound patented by Ciba-Geigy A.-G., has been utilized for angina pectoris treatment. The compound underwent evaluation in phase II clinical trials, targeting its efficacy as a cardioprotective agent.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Prisotinol, an aminoalkyl-5-pyridinol compound patented by Ciba-Geigy A.-G., has been utilized for angina pectoris treatment. The compound underwent evaluation in phase II clinical trials, targeting its efficacy as a cardioprotective agent. |
Alias | Prisotinol dihydrochloride, (+)-, PPP3N7B22F, HV83YDG8YK, C3LFG625CK |
Molecular Weight | 267.2 |
Formula | C11H20Cl2N2O |
Cas No. | 76906-72-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.